Cibc Bancorp Usa Inc. Astrazeneca PLC Transaction History
Cibc Bancorp Usa Inc.
- $80.8 Billion
- Q3 2025
A detailed history of Cibc Bancorp Usa Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Cibc Bancorp Usa Inc. holds 8,164,278 shares of AZN stock, worth $727 Million. This represents 0.77% of its overall portfolio holdings.
Number of Shares
8,164,278Holding current value
$727 Million% of portfolio
0.77%Shares
1 transactions
Others Institutions Holding AZN
# of Institutions
1,478Shares Held
492MCall Options Held
6.18MPut Options Held
3.01M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.38 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.55 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.91 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.88 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.23 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $276B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...